Related Experiment Video
Updated: Mar 22, 2026

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
16.1K
Melatonin behavior in restoring chemical damaged C2C12 myoblasts
Sara Salucci1, Valentina Baldassarri1, Barbara Canonico1
1Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, 61029, Italy.
Microscopy Research and Technique
|April 10, 2016
Summary
Melatonin protects skeletal muscle cells from oxidative stress and apoptosis by scavenging free radicals and boosting antioxidant enzymes. This suggests melatonin as a potential therapy for muscle disorders involving cell death.
Area of Science:
- Cell Biology
- Biochemistry
- Muscle Physiology
Background:
- Oxidative stress is a key factor in initiating apoptotic cell death in skeletal muscle.
- Dysregulated apoptosis is implicated in myopathies, sarcopenia, denervation, and disuse.
- Melatonin is known for its antioxidant properties and role in cellular protection.
Purpose of the Study:
- To investigate the protective effects of melatonin against oxidative stress and apoptosis in skeletal muscle cells.
- To determine the mechanisms underlying melatonin's action in myoblasts exposed to apoptotic triggers.
Main Methods:
- Undifferentiated C2C12 skeletal muscle cells were used.
- Cells were pretreated with melatonin and then exposed to chemical inducers of apoptosis (hydrogen peroxide, etoposide, staurosporine).
- Morphofunctional and molecular analyses were performed to assess cell viability and apoptosis.
Main Results:
- Melatonin pretreatment prevented oxidative stress and apoptosis induced by chemical agents in C2C12 myoblasts.
- The protective effects of melatonin were observed to involve, at least in part, the mitochondrial pathway.
- Melatonin demonstrated antioxidant and antiapoptotic activity in skeletal muscle cells.
Conclusions:
- Melatonin acts as an antioxidant and antiapoptotic agent in skeletal muscle cells.
- Melatonin's mechanism involves the mitochondrial pathway.
- Melatonin presents a potential therapeutic strategy for myopathies characterized by apoptosis misregulation.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Formation of Muscle Fibers from Myoblasts
6.7K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
6.7K

